NO20002702L - Tienopyrimidiner - Google Patents

Tienopyrimidiner

Info

Publication number
NO20002702L
NO20002702L NO20002702A NO20002702A NO20002702L NO 20002702 L NO20002702 L NO 20002702L NO 20002702 A NO20002702 A NO 20002702A NO 20002702 A NO20002702 A NO 20002702A NO 20002702 L NO20002702 L NO 20002702L
Authority
NO
Norway
Prior art keywords
thienopyrimidine
tienopyrimidines
phosphodiesterase
inhibition
therapy
Prior art date
Application number
NO20002702A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002702D0 (no
Inventor
Rochus Jonas
Franz-Werner Kluxen
Pierre Schelling
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20002702D0 publication Critical patent/NO20002702D0/no
Publication of NO20002702L publication Critical patent/NO20002702L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20002702A 1997-11-28 2000-05-26 Tienopyrimidiner NO20002702L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752952A DE19752952A1 (de) 1997-11-28 1997-11-28 Thienopyrimidine
PCT/EP1998/007436 WO1999028325A1 (de) 1997-11-28 1998-11-19 Thienopyrimidine

Publications (2)

Publication Number Publication Date
NO20002702D0 NO20002702D0 (no) 2000-05-26
NO20002702L true NO20002702L (no) 2000-05-26

Family

ID=7850200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002702A NO20002702L (no) 1997-11-28 2000-05-26 Tienopyrimidiner

Country Status (24)

Country Link
US (2) US6420368B1 (xx)
EP (1) EP1036078B1 (xx)
JP (1) JP4314341B2 (xx)
KR (1) KR20010032445A (xx)
CN (1) CN1138780C (xx)
AR (1) AR010962A1 (xx)
AT (1) ATE361926T1 (xx)
AU (1) AU742433B2 (xx)
BR (1) BR9815409A (xx)
CA (1) CA2311922C (xx)
CO (1) CO4980884A1 (xx)
CZ (1) CZ291068B6 (xx)
DE (2) DE19752952A1 (xx)
ES (1) ES2285796T3 (xx)
HK (1) HK1038924A1 (xx)
HU (1) HUP0100488A3 (xx)
ID (1) ID24571A (xx)
NO (1) NO20002702L (xx)
PL (1) PL341156A1 (xx)
RU (1) RU2217431C2 (xx)
SK (1) SK7772000A3 (xx)
TW (1) TW472059B (xx)
WO (1) WO1999028325A1 (xx)
ZA (1) ZA9810845B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
US6482948B1 (en) 1999-03-30 2002-11-19 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
DE60124085D1 (de) 2000-04-19 2006-12-07 Lilly Icos Llc Pde-v hemmer zur behandlung von morbus parkinson
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10031584A1 (de) 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10042997A1 (de) * 2000-09-01 2002-03-14 Merck Patent Gmbh Thienopyrimidine
AU2001290311A1 (en) * 2000-09-29 2002-04-08 Nippon Soda Co., Ltd. Thienopyrimidine compounds and their salts and process for preparation of both
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
PL361805A1 (en) * 2000-12-19 2004-10-04 Merck Patent Gmbh Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
CN1499969A (zh) * 2001-01-31 2004-05-26 Ĭ��ר���ɷ����޹�˾ 含有吡唑并[4,3-d]嘧啶和硝酸酯或噻吩并嘧啶和硝酸酯的药物组合物
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
WO2003035653A1 (fr) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Compose pyridothienopyrimidine et son sel
RS20050810A (xx) 2003-04-29 2007-08-03 Pfizer Inc., 5,7-diaminopirazolo(4,3-d)pirimidini korisni za lečenje hipertenzije
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
DK1742950T3 (da) 2004-04-07 2009-03-16 Pfizer Ltd Pyrazolo-[4,3-D]-pyrimidiner
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
AR088218A1 (es) 2011-07-19 2014-05-21 Infinity Pharmaceuticals Inc Compuestos heterociclicos utiles como inhibidores de pi3k
CN109297923A (zh) * 2018-09-19 2019-02-01 南通出入境检验检疫局检验检疫综合技术中心 纺织品中微量含氟整理剂的测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE245666C (xx)
DD245666A1 (de) * 1985-09-20 1987-05-13 Univ Halle Wittenberg Verfahren zur herstellung von 4-aminosubstituierten thieno 2,3-d-pyrimidin-2-ylessigsaeureestern
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
BR9815409A (pt) 2000-10-24
US6420368B1 (en) 2002-07-16
WO1999028325A1 (de) 1999-06-10
PL341156A1 (en) 2001-03-26
ID24571A (id) 2000-07-27
RU2217431C2 (ru) 2003-11-27
AU1962599A (en) 1999-06-16
TW472059B (en) 2002-01-11
US6495554B2 (en) 2002-12-17
EP1036078B1 (de) 2007-05-09
CA2311922A1 (en) 1999-06-10
ATE361926T1 (de) 2007-06-15
CN1306534A (zh) 2001-08-01
US20020132818A1 (en) 2002-09-19
ES2285796T3 (es) 2007-11-16
CZ20001962A3 (cs) 2002-01-16
ZA9810845B (en) 1999-05-26
CN1138780C (zh) 2004-02-18
KR20010032445A (ko) 2001-04-25
CO4980884A1 (es) 2000-11-27
CZ291068B6 (cs) 2002-12-11
HK1038924A1 (zh) 2002-04-04
NO20002702D0 (no) 2000-05-26
CA2311922C (en) 2009-09-29
AR010962A1 (es) 2000-07-12
JP4314341B2 (ja) 2009-08-12
SK7772000A3 (en) 2000-12-11
HUP0100488A2 (hu) 2001-09-28
HUP0100488A3 (en) 2003-03-28
JP2001525325A (ja) 2001-12-11
EP1036078A1 (de) 2000-09-20
DE19752952A1 (de) 1999-06-02
DE59814003D1 (en) 2007-06-21
AU742433B2 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
NO20002702L (no) Tienopyrimidiner
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
CA2263561A1 (en) Thienopyrimidines
NO984081L (no) Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
NO992821L (no) Ketobenzamider som calpain-inhibitorer
MY103352A (en) Piperazinyl-heterocyclic compounds
MY107157A (en) Quinuclidine derivatives.
NO307833B1 (no) Pyrimido[5,4-d]pyrimidiner, fysiologisk aksepterbare salter, legemidler inneholdende disse forbindelser og deres anvendelse
GEP20063920B (en) Alpha-(n-sulphonamido) acetamide derivatives as beta-amyloid inhibitors
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
TW225532B (xx)
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
DK1107973T3 (da) Hidtil ukendte thieno(2,3-D)pyrimidindioner, fremgangsmåde til deres fremstilling og anvendelse deraf i terapi
MY115211A (en) Novel amino acid derivatives, their preparation and use
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
DE50211929D1 (en) Pyrimidinderivate
GEP20043267B (en) Adenosine Receptor Antagonists, Methods of Making and Using the Same
MY121864A (en) Condensed thienopyrimidines with phosphodiesterase-v inhibiting action.
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application